Wednesday, September 17, 2014 10:13:17 AM
WHO Orders Global Response as Ebola Death Toll Climbs to 2,500
The Ebola virus outbreak is “unparalleled in modern times,” the World Health Organization said Tuesday, announcing a "global response coalition" as the death toll in West Africa climbed towards 2,500 with 5,000 others infected.
"The gravity is the situation is difficult to get across,” said Bruce Aylward, Assistant Director-General of the WHO. The response coalition will be led by U.N. Secretary General Ban Ki Moon.
"We must prevent the collapse of the health systems in the affected countries," said Valerie Amos, Under-Secretary-General for Humanitarian Affairs and Emergency. "The food security situation in some parts of the affected countries is of grave concern." President Barack Obama was due to announce a major military-led surge in U.S. aid to fight the outbreak later Tuesday, with as many as 3,000 troops to help organize, train new health care workers and build treatment clinics.
Aylward said a faster response was needed to keep the numbers infected within the "tens of thousands."
http://www.nbcnews.com/storyline/ebola-virus-outbreak/who-orders-global-response-ebola-death-toll-climbs-2-500-n204241
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM